Search Results - "GilMartin, Marta"
-
1
638 Characterisation of the immune response to EO2401, a new immunotherapy approach against cancer, plus nivolumab in recurrent glioblastoma: The EOGBM1–18/ROSALIE study
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundEO2401 is a novel generation of cancer immunotherapies designed to activate memory T cells that recognize commensal-derived peptides and cross-react…”
Get full text
Journal Article -
2
716 Phase 2 study of the HER2-targeting TLR7/8 immune stimulating antibody conjugate (ISAC) BDC-1001 monotherapy +/- nivolumab in patients with HER2+ colorectal, endometrial, or gastroesophageal cancer
Published in Journal for immunotherapy of cancer (01-11-2023)“…BackgroundDespite advances made in management of patients with HER2-driven solid tumors, unmet need remains for novel approaches to improve patient outcomes…”
Get full text
Journal Article -
3
CTIM-25. EO2401 PEPTIDE IMMUNOTHERAPY + NIVOLUMAB +/- BEVACIZUMAB IN FIRST RECURRENT GLIOBLASTOMA: THE PHASE 1/2 EOGBM1-18/ROSALIE STUDY (NCT04116658)
Published in Neuro-oncology (Charlottesville, Va.) (10-11-2023)“…EO2401 expands existing memory T cells recognizing protein sequences from gut bacteria, which cross-react with tumor associated antigens (TAAs). EO2401…”
Get full text
Journal Article